Physician profile
Pradeep Yadav
NPI 1366605552
$655,585.71
in general payments reported to CMS, 2019-2025
17 companies · $135K in 2025
The $135K reported for 2025 was more than what 99% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $103K · 2020: $78K · 2021: $43K · 2022: $111K · 2023: $80K · 2024: $106K · 2025: $135K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $260K · Travel and Lodging: $31K · Food and Beverage: $16K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $9,875 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $2,875 · Long Term Medical Supply Or Device Loan: $282 · Education: $12.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $259,973.50 |
| Travel and Lodging | $31,490.02 |
| Food and Beverage | $16,135.72 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $9,875.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $2,875.00 |
| Long Term Medical Supply Or Device Loan | $281.66 |
| Education | $12.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $444,753.66 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Evoque, Pascal |
| Abbott Laboratories | $148,725.14 | 2019-2025 | Mitraclip, Navitor, Amplatzer Amulet |
| Boston Scientific Corporation | $39,593.65 | 2019-2025 | General - Structural Heart, Watchman Access System, Watchman Flx |
| Shockwave Medical, INC | $12,062.95 | 2020-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Livanova USA, INC. | $5,643.19 | 2019 | |
| Siemens Medical Solutions USA, INC. | $2,449.30 | 2021 | |
| Medtronic Vascular, INC. | $1,646.88 | 2019-2020 | |
| Jenavalve Technology, INC. | $328.27 | 2023 | Jenavalve Pericardial Tavr System |
| Medtronic, INC. | $127.08 | 2021-2025 | Penditure, Venaseal |
| Artivion, INC. | $101.66 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $50.34 | 2023 | Camzyos |
| Angiodynamics, INC. | $49.90 | 2025 | Angiovac |
| W. L. Gore & Associates, INC. | $15.93 | 2021 | |
| Resmed Corp | $13.31 | 2022 | |
| Baxter Healthcare | $12.47 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Chiesi USA, INC. | $11.98 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$7,200.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pradeep Yadav listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.